Jaguar Health, Inc.: Jaguar Health Announces Completion of K

Jaguar Health, Inc.: Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer

Milestone supports the expansion of manufacturing volume required for potential additional indications for crofelemer, including cancer therapy-related diarrheaCrofelemer API (active pharmaceutical ingredient)

Related Keywords

Italy , Milan , Lombardia , Italian , David Sesin , Peter Hodge , Jaguar Health , Jaguar Animal Health , Jaguar Health Inc , Napo Therapeutics Jaguar Animal Health , Nasdaq , Napo Pharmaceuticals , Napo Pharmaceuticals Inc , Jaguar Health Inc View , Italian Medicines Agency , Agenzia Italiana Del Farmaco , Napo Therapeutics , Jaguar Animal , Inc View , Jaguar , Health , Nnounces , Completion , Milestone , Process , Establishing , Condena , Eliable , Approved , Crofelemer , Manufacturer ,